What is the address of ORTHOCITA?

The registered office of ORTHOCITA is located at Avenue de la Laiterie 52, 4000 Liège.

Is ORTHOCITA still active?

Yes. According to the CBE (31 October 2026) ORTHOCITA is active, legal situation “Normale toestand”, started on 28 December 2018.

Is ORTHOCITA registered on Peppol?

Yes, ORTHOCITA is registered on the Peppol network with ID 0208:0716949170.

What is the enterprise number of ORTHOCITA?

The enterprise number of ORTHOCITA is BE0716949170.

When was ORTHOCITA founded?

ORTHOCITA was founded on 28 December 2018.

Is ORTHOCITA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 2018; 5 annual accounts filed, latest fiscal year 2025; 6 directors known from the annual account.

How much profit did ORTHOCITA make in 2025?

ORTHOCITA posted a profit after taxes of € 4,848 in financial year 2025.

What is the revenue of ORTHOCITA?

As a small company, ORTHOCITA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 7,500.

ORTHOCITA (Private Limited) - Liège - BE0716949170

Q: Who are the directors of ORTHOCITA?

According to the 2025 annual accounts, the directors of ORTHOCITA are: CABINET D'ORTHOPEDIE S. LEMPEREUR, SPRL SRL, Docteur Amon SRL, VDB ORTHO SRL, Docteur Piron Maud Orthopédie SRL, DOCTEUR SEBASTIEN FIGIEL SRL, FP MEDICAL SRL.

Dossier ORTHOCITA, printed on 1 November 2026 from databakkes.be/en/0716949170/orthocita. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ORTHOCITA from Liège, company number BE0716949170, closed financial year 2025 with a result of € 4,848 after tax. For that financial year ORTHOCITA recorded a gross margin of € 7,500 and equity of € 17,613. Compared with financial year 2024, the result moved from € 2,352 to € 4,848. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 17,613

▲ 38% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4,848

▲ 106% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 196,099

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 17,613.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 1,900

▲ 113% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 6,470 Gross margin 2022: € 6,470 First fiscal year in the series	€ 4,955 Gross margin 2023: € 4,955 ▼ 23% vs 2022 (€ 6,470) Unfavourable step	€ 4,442 Gross margin 2024: € 4,442 ▼ 10% vs 2023 (€ 4,955) Unfavourable step	€ 7,500 Gross margin 2025: € 7,500 ▲ 69% vs 2024 (€ 4,442) Favourable step	▲ 69%
Profit after taxes	€ 4,235 Profit after taxes 2022: € 4,235 First fiscal year in the series	€ 3,013 Profit after taxes 2023: € 3,013 ▼ 29% vs 2022 (€ 4,235) Unfavourable step	€ 2,352 Profit after taxes 2024: € 2,352 ▼ 22% vs 2023 (€ 3,013) Unfavourable step	€ 4,848 Profit after taxes 2025: € 4,848 ▲ 106% vs 2024 (€ 2,352) Favourable step	▲ 106%
Equity	€ 7,400 Equity 2022: € 7,400 First fiscal year in the series	€ 10,413 Equity 2023: € 10,413 ▲ 41% vs 2022 (€ 7,400) Favourable step	€ 12,765 Equity 2024: € 12,765 ▲ 23% vs 2023 (€ 10,413) Favourable step	€ 17,613 Equity 2025: € 17,613 ▲ 38% vs 2024 (€ 12,765) Favourable step	▲ 38%
Total debts	€ 483,478 Total debts 2022: € 483,478 First fiscal year in the series	€ 456,910 Total debts 2023: € 456,910 ▼ 5% vs 2022 (€ 483,478) Favourable step	€ 520,481 Total debts 2024: € 520,481 ▲ 14% vs 2023 (€ 456,910) Unfavourable step	€ 598,920 Total debts 2025: € 598,920 ▲ 15% vs 2024 (€ 520,481) Unfavourable step	▲ 15%
Cash	€ 145,129 Cash 2022: € 145,129 First fiscal year in the series	€ 164,118 Cash 2023: € 164,118 ▲ 13% vs 2022 (€ 145,129) Favourable step	€ 208,905 Cash 2024: € 208,905 ▲ 27% vs 2023 (€ 164,118) Favourable step	€ 196,099 Cash 2025: € 196,099 ▼ 6% vs 2024 (€ 208,905) Unfavourable step	▼ 6%
Retained profit	€ 7,400 Retained profit 2022: € 7,400 First fiscal year in the series	€ 10,413 Retained profit 2023: € 10,413 ▲ 41% vs 2022 (€ 7,400) Favourable step	€ 12,765 Retained profit 2024: € 12,765 ▲ 23% vs 2023 (€ 10,413) Favourable step	€ 17,613 Retained profit 2025: € 17,613 ▲ 38% vs 2024 (€ 12,765) Favourable step	▲ 38%
Balance sheet total	€ 490,878 Balance sheet total 2022: € 490,878 First fiscal year in the series	€ 467,323 Balance sheet total 2023: € 467,323 ▼ 5% vs 2022 (€ 490,878) Unchanged	€ 533,246 Balance sheet total 2024: € 533,246 ▲ 14% vs 2023 (€ 467,323) Unchanged	€ 616,533 Balance sheet total 2025: € 616,533 ▲ 16% vs 2024 (€ 533,246) Unchanged	▲ 16%

Key figures of ORTHOCITA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ORTHOCITA?

What happened at ORTHOCITA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 4,848 (▲ 106% vs 2024). Source: NBB ↗
Dec 28, 2018 New establishment in Dalhem. KBO
Dec 28, 2018 Start of the company according to the CBE. KBO

In short

From € 4,235 profit in 2022 to € 4,848 profit in 2025.

Paid € 6,012 in corporate taxes since 2022.

Best year ever: 2025, with € 4,848 profit.

Original PDFs at the National Bank ↗

Management

CABINET D'ORTHOPEDIE S. LEMPEREUR, SPRL SRL Docteur Amon SRL VDB ORTHO SRL Docteur Piron Maud Orthopédie SRL +2

ORTHOCITA

Behind ORTHOCITA are CABINET D'ORTHOPEDIE S. LEMPEREUR, SPRL SRL, Docteur Amon SRL, VDB ORTHO SRL, Docteur Piron Maud Orthopédie SRL, DOCTEUR SEBASTIEN FIGIEL SRL and FP MEDICAL SRL.